CEL-SCI Corp. (CVM) - Koefisien rega marang bathi
CEL-SCI Corporation (CVM) develops immunotherapies to combat head and neck tumors, and the price trend for this asset on GURU.Markets currently stands at -0.90. A cohesive team of scientists dedicated to achieving a scientific breakthrough is working on the project; however, the business relies on dwindling reserves due to high R&D expenses in the absence of profit.
Rincian metrik komprehensif lan analitis CEL-SCI Corp. (CVM)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi pasar:
- data ekuitas miturut neraca:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal CEL-SCI Corporation|CVM - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas CEL-SCI Corp|CVM - Gunggung utang perusahaan|Utang-utang marang nilai buku CEL-SCI Corporation|CVM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan CEL-SCI|Likuiditas kritis cel-sci.com
- data bathi resik lan rasio valuasi:
CVM - Bathi resik perusahaan|Prakiraan bathi perusahaan CEL-SCI Corporation|CVM - Pangali P/E|Prakiraan rega marang bathi CEL-SCI Corp|CVM - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan CEL-SCI Corporation|CVM - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku CEL-SCI|CVM - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cel-sci.com|CVM - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep CEL-SCI Corporation
Ringkesan analisis perusahaan:CVM (cel-sci.com)
CEL-SCI Corporation revenues depend on the successful market launch of the immunotherapy drug Multikine for the treatment of head and neck oncology. By analyzing the company's normalized P/E, an investor assesses the ratio of current market capitalization to net income, which allows for determining the premium paid for the future commercialization potential of biotechnological developments and estimating the investment payback period.
Analisis perusahaan pesaing
ONC: Nilai perusahaan marang bathi resik|Pangali P/E HALO|Koefisien rega marang bathi Revolution Medicines Inc RVMD|Ascentage - Koefisien rega marang bathi|Pangali P/E CG Oncology Therapeutics CGON|URGN - Rasio rega marang bathi|Nilai perusahaan marang bathi resik BCAX (bicara.com)|PSNL: Pangali P/E|Kapitalisasi marang bathi Erasca Inc (ERAS)|DCTH (Delcath) - Pangali P/E|Koefisien rega marang bathi Y-mAbs Corp (YMAB)|Pangali P/E AURA|CADL - Kapitalisasi marang bathi|Rasio rega marang bathi Accuray ARAY|SELLAS Life Sciences Group, Inc. - Rasio rega marang bathi|ACTU: Koefisien rega marang bathi|Rasio kapitalisasi marang bathi resik Citius Oncology Inc (CTOR)|tuhurabio.com (HURA) - Rasio rega marang bathi|TARA - Periode bali modal bisnis|FATE (Fate Therapeutics) - Pangali P/E|Koefisien rega marang bathi Aadi Bio (WHWK)|Pangali P/E TCRX|Periode bali modal bisnis championsoncology.com|XBiotech - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik OSTX|Radiopharm Theranostics - Pangali P/E|Artiva Biotherapeutics, Inc. (ARTV) - Koefisien rega marang bathi|adlainortye.com (ANL) - Rasio rega marang bathi|Kapitalisasi marang bathi Veru Corporation (VERU)|Rasio rega marang bathi Tempest Therapeutics|XLO: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Renovaro Inc. (RENB)|MURA: Kapitalisasi marang bathi resik|Rasio rega marang bathi Kairos Pharma KAPA|OnKure Therapeutics, Inc. (OKUR) - Kapitalisasi marang bathi|GDTC - Rasio rega marang bathi|Nilai perusahaan marang bathi resik CRIS (Curis, Inc.)|APLM: Pangali P/E|Tharimmune Inc (THAR) - Pangali P/E|Koefisien rega marang bathi ADVB|GNPX (Genprex Inc) - Rasio rega pasar marang bathi resik|Pangali P/E CLDI|Periode bali modal bisnis sunshinebiopharma.com|Rasio rega marang bathi Xenetic Biosciences, Inc. XBIO|Salarius Pharmaceuticals Inc (SLRX) - Kapitalisasi marang bathi|PPBT - Rasio rega marang bathi|AONC (American Oncology Network) - Pangali rega marang bathi|BGNE: Pangali P/E|Koefisien rega marang bathi checkpointtx.com|Koefisien rega marang bathi ELEV|Rasio rega marang bathi ICAD|Rasio rega marang bathi Ikena Oncology, Inc. (IKNA)|Koefisien rega marang bathi Notable Labs Corp NTBL|Pangali P/E VIRX (Viracta Therapeutics, Inc.)|MOR - Koefisien rega marang bathi|NAYA Biosciences Inc. - Pangali P/E|AAPGV - Pangali P/E
